111 related articles for article (PubMed ID: 9685944)
1. Release rates from topical formulations containing drugs in suspension.
Bunge AL
J Control Release; 1998 Mar; 52(1-2):141-8. PubMed ID: 9685944
[TBL] [Abstract][Full Text] [Related]
2. Modeling of drug release from matrix systems involving moving boundaries: approximate analytical solutions.
Lee PI
Int J Pharm; 2011 Oct; 418(1):18-27. PubMed ID: 21251957
[TBL] [Abstract][Full Text] [Related]
3. Higuchi equation: derivation, applications, use and misuse.
Siepmann J; Peppas NA
Int J Pharm; 2011 Oct; 418(1):6-12. PubMed ID: 21458553
[TBL] [Abstract][Full Text] [Related]
4. Vehicle effects in percutaneous absorption: in vitro study of influence of solvent power and microscopic viscosity of vehicle on benzocaine release from suspension hydrogels.
Di Colo G; Carelli V; Giannaccini B; Serafini MF; Bottari F
J Pharm Sci; 1980 Apr; 69(4):387-91. PubMed ID: 7373530
[TBL] [Abstract][Full Text] [Related]
5. Use of gelatin-acacia coacervate containing benzocaine in topical formulations.
Ichwan AM; Karimi M; Dash AK
J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539
[TBL] [Abstract][Full Text] [Related]
6. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
[TBL] [Abstract][Full Text] [Related]
7. Equilibrium solubility measurement of compounds with low dissolution rate by Higuchi's Facilitated Dissolution Method. A validation study.
Takács-Novák K; Urac M; Horváth P; Völgyi G; Anderson BD; Avdeef A
Eur J Pharm Sci; 2017 Aug; 106():133-141. PubMed ID: 28577995
[TBL] [Abstract][Full Text] [Related]
8. Drug Release from a Spherical Matrix: Theoretical Analysis for a Finite Dissolution Rate Affected by Geometric Shape of Dispersed Drugs.
Lin YS; Tsay RY
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585967
[TBL] [Abstract][Full Text] [Related]
9. Effect of particle dissolution rate on ocular drug bioavailability.
Hui HW; Robinson JR
J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
[TBL] [Abstract][Full Text] [Related]
10. Drug release from a suspension with a finite dissolution rate: theory and its application to a betamethasone 17-valerate patch.
Kubota K; Twizell EH; Maibach HI
J Pharm Sci; 1994 Nov; 83(11):1593-9. PubMed ID: 7891281
[TBL] [Abstract][Full Text] [Related]
11. Release of hydrocortisone from a cream matrix: dependency of release on suspension concentration and measurement of solubility and diffusivity.
Pillai R; Shah V; Abriola L; Caetano P; Flynn GL
Pharm Dev Technol; 2001 Aug; 6(3):373-84. PubMed ID: 11485179
[TBL] [Abstract][Full Text] [Related]
12. Prediction of blood levels following oral administration of weakly acidic drug particles such as sulfa drugs in rabbits from the in vitro dissolution behavior.
Watari N; Kaneniwa N
J Pharmacobiodyn; 1984 Jun; 7(6):351-65. PubMed ID: 6481612
[TBL] [Abstract][Full Text] [Related]
13. Diffusion model for drug release from suspensions I: theoretical considerations.
Ayres JW; Lindstrom FT
J Pharm Sci; 1977 May; 66(5):654-62. PubMed ID: 874746
[TBL] [Abstract][Full Text] [Related]
14. Application of organogels as oral controlled release formulations of hydrophilic drugs.
Iwanaga K; Kawai M; Miyazaki M; Kakemi M
Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
[TBL] [Abstract][Full Text] [Related]
15. Novel mathematical method for quantitative expression of deviation from the higuchi model.
Gohel MC; Panchal MK; Jogani VV
AAPS PharmSciTech; 2000 Oct; 1(4):E31. PubMed ID: 14727896
[TBL] [Abstract][Full Text] [Related]
16. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
George K
Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
[TBL] [Abstract][Full Text] [Related]
17. Self-emulsifying oils for ocular drug delivery. II. In vitro release of indomethacin and hydrocortisone.
Czajkowska-Kośnik A; Sznitowska M; Mirkowska K
Acta Pol Pharm; 2012; 69(2):309-17. PubMed ID: 22568046
[TBL] [Abstract][Full Text] [Related]
18. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
[TBL] [Abstract][Full Text] [Related]
19. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive assessment of anesthetic activity of topical lidocaine formulations.
Kushla GP; Zatz JL; Mills OH; Berger RS
J Pharm Sci; 1993 Nov; 82(11):1118-22. PubMed ID: 8289124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
